RUA Life Sciences PLC Result of AGM (2352W)
16 Agosto 2022 - 12:06PM
UK Regulatory
TIDMRUA
RNS Number : 2352W
RUA Life Sciences PLC
16 August 2022
16 August 2022
RUA Life Sciences plc
("RUA", the "Company" or the "Group")
Result of AGM
RUA Life Sciences plc (AIM: RUA.L), the holding company of a
group of medical device businesses focused on the exploitation of
the world's leading long-term implantable biostable polymer
(Elast-Eon(TM) ), announces that all resolutions put forward to its
Annual General Meeting held earlier today were duly passed and the
votes cast were as follows:
Res No. Votes % Votes Against % Votes Total % I.S.C. Votes
For Withheld
01 2,517,502 100.00% 0 0.00% 2,517,502 11.35 11,763
----------- -------- ------------------ ------- ------------- --------- ------------
02 1,164,389 96.51% 42,142 3.49% 1,206,531 5.44 1,322,734
----------- -------- ------------------ ------- ------------- --------- ------------
03 2,517,502 100.00% 0 0.00% 2,517,502 11.35 11,763
----------- -------- ------------------ ------- ------------- --------- ------------
04 2,517,502 100.00% 0 0.00% 2,517,502 11.35 11,763
----------- -------- ------------------ ------- ------------- --------- ------------
05 1,900,843 94.80% 104,178 5.20% 2,005,021 9.04 524,244
----------- -------- ------------------ ------- ------------- --------- ------------
06 2,413,324 95.86% 104,178 4.14% 2,517,502 11.35 11,763
----------- -------- ------------------ ------- ------------- --------- ------------
07 2,517,487 100.00% 15 0.00% 2,517,502 11.35 11,763
----------- -------- ------------------ ------- ------------- --------- ------------
08 2,508,972 99.66% 8,530 0.34% 2,517,502 11.35 11,763
----------- -------- ------------------ ------- ------------- --------- ------------
09 2,404,481 95.51% 112,921 4.49% 2,517,402 11.35 11,863
----------- -------- ------------------ ------- ------------- --------- ------------
10 2,404,385 95.51% 112,921 4.49% 2,517,306 11.35 11,959
----------- -------- ------------------ ------- ------------- --------- ------------
For further information contact:
RUA Life Sciences
Bill Brown, Chairman Tel: +44 (0)1294 317073
Dr Caroline Stretton, Group MD Tel: +44 (0)1294 317073
Cenkos Securities plc (Nominated Adviser and Broker) Tel: +44 (0)20 7397 8900
Giles Balleny/Max Gould (Corporate Finance)
Michael Johnson (Sales)
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when RUA
Life Sciences Plc (formerly known as AorTech International Plc)
acquired RUA Medical Devices Limited to create a fully formed
medical device business. RUA Life Sciences is the holding company
of the Group's four trading businesses, each exploiting the Group's
patented polymer technology.
Our vision is to improve the lives of millions of patients by
enabling medical devices with Elast-Eon(TM) , the world's leading
long-term implantable polyurethane. Whether it is licensing
Elast-Eon(TM) , manufacturing a device or component, or developing
next generation medical devices, a RUA Life Sciences business is
pursuing our vision.
Elast-Eon(TM)'s biostability is comparable to silicone while
exhibiting excellent mechanical, blood contacting and flex-fatigue
properties. These polymers can be processed using conventional
thermoplastic extrusion and moulding techniques. With over 8
million implants and 15 years of successful clinical use, RUA's
polymers are proven in long-term life enabling applications.
The Group's four business units are:
RUA Medical: End-to-end contract developer and manufacturer
of medical devices and implantable fabric
specialist.
RUA Biomaterials: Licensor of Elast-Eon(TM) polymers to the
medical device industry.
RUA Vascular: Commercialisation of open surgical vascular
grafts and patches
RUA Structural Development of polymeric leaflet systems
Heart: for heart valves.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGPFMRTMTMBBAT
(END) Dow Jones Newswires
August 16, 2022 13:06 ET (17:06 GMT)
Aortech (LSE:AOR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Aortech (LSE:AOR)
Gráfica de Acción Histórica
De May 2023 a May 2024